BLTE — BELITE BIO INC
As of Q2 2026, 17 SEC-registered investment managers reported holding BLTE (BELITE BIO INC) in their latest 13F filings, with a combined reported value of $314.48M across 2.15M shares. That is +6.3% by share count (+127.28K shares) versus the previous quarter, while reported value moved +13.4%. Ownership is concentrated: the five largest holders account for 75.3% of reported value and the top ten for 96.6%.
Compared with the prior quarter, 5 opened new positions, 7 added to existing stakes, 4 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
BLTE is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Millennium Management history | Q2 2026 | 494.56K | $76.16M | 0.03% | Reduce |
| Maverick Capital history | Q2 2026 | 396.31K | $61.03M | 0.55% | New |
| Morgan Stanley history | Q2 2026 | 235.07K | $36.20M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 224.99K | $34.64M | 0.01% | Reduce |
| Marshall Wace history | Q4 2025 | 192.70K | $30.82M | 0.03% | Add |
| Citadel Advisors history | Q2 2026 | 186.17K | $28.67M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 166.19K | $25.59M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 124.78K | $19.21M | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 55.76K | $8.59M | 0.01% | Add |
| Point72 Asset Management history | Q2 2026 | 51.19K | $7.88M | 0.01% | New |
| Two Sigma Investments history | Q2 2026 | 38.10K | $5.87M | 0.01% | New |
| JPMorgan Chase & Co history | Q2 2026 | 33.18K | $5.13M | 0.00% | New |
| Geode Capital Management history | Q2 2026 | 22.64K | $3.49M | 0.00% | Add |
| Manulife Financial history | Q2 2026 | 9.82K | $1.51M | 0.00% | Reduce |
| Wellington Management Group history | Q4 2025 | 6.20K | $991.43K | 0.00% | New |
| Amundi US history | Q1 2026 | 4.21K | $671.24K | 0.00% | New |
| Fidelity Management & Research (FMR) history | Q2 2026 | 3.10K | $477.35K | 0.00% | New |
| Farallon Capital Management history | Q1 2026 | 1.30K | $207.27K | 0.00% | New |
| Wells Fargo & Co history | Q2 2026 | 124 | $19.09K | 0.00% | Hold |
| T. Rowe Price Associates history | Q2 2026 | 105.86K | $16.30K | 0.00% | Reduce |
New Positions (Q2 2026)
- Maverick Capital 396.31K sh · $61.03M
- Point72 Asset Management 51.19K sh · $7.88M
- Two Sigma Investments 38.10K sh · $5.87M
- JPMorgan Chase & Co 33.18K sh · $5.13M
- Fidelity Management & Research (FMR) 3.10K sh · $477.35K
Fully Exited (vs previous quarter)
- Amundi US sold 4.21K sh · $671.24K
- Farallon Capital Management sold 1.30K sh · $207.27K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Millennium Management | 8.99K | — | — | — | — | — | — | — | — | — | — | — | — | 20.74K | 558.88K | 570.09K | 494.56K |
| Maverick Capital | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 396.31K |
| Morgan Stanley | — | 18.31K | 2.00K | 1.04K | 438 | 438 | 22.42K | 6.09K | 1.04K | 662 | 10.62K | 316 | 507 | 5.23K | 28.01K | 201.41K | 235.07K |
| UBS Group AG | 683 | — | 4.22K | 120 | 300 | 883 | 348 | — | — | 128 | 12.21K | 551 | 2.36K | 11.33K | 128.75K | 768.36K | 224.99K |
| Citadel Advisors | — | — | — | — | — | — | — | — | — | 6.46K | 5.21K | 5.69K | 7.46K | 10.83K | 5.05K | 2.01K | 186.17K |
| Goldman Sachs Group | — | — | — | — | — | — | — | — | — | — | 6.33K | — | — | 3.71K | 44.60K | 105.51K | 166.19K |
| Bank of America Corp | — | — | — | — | — | 63 | 2.21K | 1.72K | 102 | 13.45K | 18.34K | 5.22K | 914 | 1.17K | 1.85K | 3.78K | 124.78K |
| Renaissance Technologies | — | — | — | — | — | — | 4.90K | — | — | — | — | — | 4.30K | 2.81K | — | 52.00K | 55.76K |
| Point72 Asset Management | — | — | — | — | — | — | 7.70K | 8.70K | 7.31K | 4.80K | — | — | 1.30K | 3.10K | 284.44K | — | 51.19K |
| Two Sigma Investments | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 38.10K |
| JPMorgan Chase & Co | — | 7.40K | — | — | — | — | 14.27K | 658 | 88 | 6.36K | 14.64K | 8.16K | 6.76K | 9.81K | 3 | — | 33.18K |
| Geode Capital Management | — | 7.26K | — | — | — | 6.70K | 6.70K | 6.70K | 6.70K | 6.70K | 6.70K | 12.75K | 12.86K | 15.62K | 10.45K | 10.43K | 22.64K |
| Manulife Financial | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 19.60K | 9.82K |
| Fidelity Management & Research (FMR) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 3.10K |
| Wells Fargo & Co | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 100 | 124 | 124 |
| T. Rowe Price Associates | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 281.81K | 105.86K |
| Citigroup Inc | — | — | — | — | — | — | — | — | — | — | — | 3 | — | 4.01K | 2.14K | 1 | 47 |
| Amundi US | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 4.21K | — |
| Farallon Capital Management | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1.30K | — |
| Marshall Wace | — | — | — | — | — | — | 16.01K | 10.58K | — | 8.49K | 5.87K | — | 9.49K | 187.50K | 192.70K | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details